Can reminders and education prevent cervical cancer? a new trial aims to find out.
NCT ID NCT04452526
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether a program that combines educational materials with electronic health record reminders can increase HPV vaccination rates among children and young adults aged 11–26 in four Appalachian states. The goal is to improve vaccine uptake and ultimately prevent cervical cancer. Researchers are comparing clinics that start the program early versus those that start later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
educational materials and reminder letters
What this could lead to
If successful, this approach could help prevent cervical cancer by increasing HPV vaccination rates in underserved communities.
What could go wrong
The trial is relatively small and focuses on a specific region, so results may not apply elsewhere. It tests a behavioral intervention, not a new vaccine or drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
University of Kentucky/Markey Cancer Center
Lexington, Kentucky, 40536, United States
-
University of Virginia
Charlottesville, Virginia, 22908, United States
-
West Virginia University
Morgantown, West Virginia, 26506, United States